Natera and Institut Jules Bordet announce collaboration in neoadjuvant breast cancer
Natera announced a research collaboration with the Institut Jules Bordet, an internationally renowned multidisciplinary cancer reference center in Belgium, using the company's Signatera™ research-use-only circulating tumor DNA assay to evaluate molecular response. June 19, 2018